Psoriatic Arthritis — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Tumour-necrosis-factor inhibitors
Tumour-necrosis-factor blockade is avoided in people with demyelinating disease because new or worsening demyelination has been reported. Selection among other targeted therapies should account for psoriasis phenotype, comorbidity, infection risk and current UK commissioning guidance.
Reference: https://www.nice.org.uk/guidance/cg153/chapter/recommendations